Charles River Laboratories International, Inc. (CRL) Key Metrics

NYSE: CRLValuation, returns, debt and efficiency ratios over 10 years.

CRL valuation today

Trailing 12 months · as of October 18, 2026
Market cap
$14.46B
Enterprise value
$16.08B
P/E (TTM)
—
10-yr median 30.1
Forward P/E
22.4
PEG ratio
0.12
Price / sales
3.6
10-yr median 2.8
Price / book
4.7
10-yr median 4.3
EV / EBITDA
72.9
10-yr median 15.6
Dividend yield
—
Beta
1.40

CRL key metrics, 2016–2025

Fiscal year ended December 31, 2025 · U.S. dollars

CRL valuation Price multiples at each fiscal year-end price.

Price / sales+4.6%
2.5
2025 · hover or tap a bar for each year
2016: 2.2 (−22.6%)2017: 2.9 (+31.7%)2018: 2.4 (−14.4%)2019: 2.9 (+18.3%)2020: 4.3 (+49.3%)2021: 5.5 (+26.6%)2022: 2.8 (−48.6%)2023: 2.9 (+4.8%)2024: 2.4 (−20.1%)2025: 2.5 (+4.6%)
20162025
Price / book+13.5%
3.1
2025 · hover or tap a bar for each year
2016: 4.4 (−16.4%)2017: 5.1 (+16.5%)2018: 4.2 (−17.2%)2019: 4.6 (+10.3%)2020: 6.0 (+28.8%)2021: 7.6 (+27.8%)2022: 3.8 (−50.9%)2023: 3.4 (−10.0%)2024: 2.8 (−18.6%)2025: 3.1 (+13.5%)
20162025
EV / EBITDA+49.4%
31.0
2025 · hover or tap a bar for each year
2016: 12.6 (−15.6%)2017: 13.8 (+8.7%)2018: 13.9 (+1.1%)2019: 16.7 (+19.8%)2020: 19.0 (+13.9%)2021: 27.2 (+43.6%)2022: 14.2 (−47.7%)2023: 14.5 (+1.7%)2024: 20.8 (+43.2%)2025: 31.0 (+49.4%)
20162025
Price / free cash flow+0.4%
19.1
2025 · hover or tap a bar for each year
2016: 15.0 (−12.4%)2017: 22.7 (+51.2%)2018: 18.4 (−18.9%)2019: 22.3 (+21.0%)2020: 33.3 (+49.2%)2021: 36.4 (+9.4%)2022: 37.9 (+4.1%)2023: 33.3 (−12.2%)2024: 19.0 (−42.9%)2025: 19.1 (+0.4%)
20162025
Free cash flow yield0.0 pts
5.2%
2025 · hover or tap a bar for each year
2016: 6.7% (+0.8 pts)2017: 4.4% (−2.3 pts)2018: 5.4% (+1.0 pts)2019: 4.5% (−0.9 pts)2020: 3.0% (−1.5 pts)2021: 2.7% (−0.3 pts)2022: 2.6% (−0.1 pts)2023: 3.0% (+0.4 pts)2024: 5.3% (+2.3 pts)2025: 5.2% (0.0 pts)
20162025

CRL valuation history

Fiscal year-endToday10-year median

CRL returns on capital

ROEROICROA

Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.

CRL debt vs cash

Total debtCash & short-term investments

Debt includes short- and long-term borrowings and, where reported, lease liabilities.

CRL cash returned to shareholders

DividendsBuybacksFree cash flow

CRL price vs earnings per share

Share price at year-endEPS (right axis)

CRL key metrics

2016–2025
Charles River Laboratories International, Inc. key metrics by fiscal year
2025202420232022202120202019201820172016
Valuation
Market capitalization$9.89B$9.53B$12.16B$11.18B$19.38B$12.65B$7.59B$5.55B$5.32B$3.65B
Enterprise value$12.74B$12.06B$14.95B$14.04B$22.34B$14.58B$9.38B$7.05B$6.30B$4.77B
P/E ratio—925.625.623.049.634.730.124.543.123.6
Price / sales2.52.42.92.85.54.32.92.42.92.2
Price / book3.12.83.43.87.66.04.64.25.14.4
Price / free cash flow19.119.033.337.936.433.322.318.422.715.0
Price / operating cash flow13.413.017.818.025.523.115.812.616.812.2
EV / sales3.23.03.63.56.35.03.63.13.42.8
EV / EBITDA31.020.814.514.227.219.016.713.913.812.6
EV / free cash flow24.624.040.947.642.038.427.523.426.919.6
Earnings yield−1.5%0.1%3.9%4.3%2.0%2.9%3.3%4.1%2.3%4.2%
Free cash flow yield5.2%5.3%3.0%2.6%2.7%3.0%4.5%5.4%4.4%6.7%
Dividend yield——0.2%—0.2%0.4%0.5%—0.0%0.0%
Shareholder yield (dividends + buybacks)3.6%1.3%0.4%0.3%0.4%0.6%0.7%0.2%2.0%0.3%
Share price at fiscal year-end$199.48$184.60$236.40$217.90$376.78$249.86$152.76$113.18$109.45$76.19
Per share
Revenue per share$81.01$78.45$80.26$77.50$68.84$57.77$52.75$46.23$38.25$35.06
Earnings per share−$2.91$0.20$9.22$9.48$7.60$7.20$5.07$4.62$2.54$3.23
Operating cash flow per share$14.88$14.23$13.29$12.08$14.79$10.80$9.68$9.00$6.51$6.22
Free cash flow per share$10.46$9.72$7.10$5.75$10.35$7.51$6.85$6.14$4.81$5.07
Cash per share$4.31$3.77$5.38$4.56$4.79$4.53$4.81$3.99$3.37$2.45
Book value per share$63.85$67.05$69.91$58.02$49.29$41.78$32.89$26.87$21.52$17.45
Tangible book value per share$1.22−$2.10−$7.04−$16.16−$24.08−$9.53−$11.98−$11.03−$2.67−$7.20
Dividends per share——$0.50—$0.89$0.92$0.70—$0.00$0.00
Capex per share$4.42$4.51$6.19$6.33$4.45$3.29$2.83$2.86$1.70$1.15
Debt per share$61.85$52.76$59.60$60.37$62.33$42.68$40.75$34.63$23.58$25.75
Shares outstanding49.6M51.6M51.5M51.3M51.4M50.6M49.7M49.0M48.6M48.0M
Change in shares outstanding−4.0%+0.3%+0.3%−0.2%+1.6%+1.8%+1.4%+0.9%+1.3%+0.7%
Returns & profitability
Return on equity (ROE)−4.4%0.3%14.4%17.6%16.8%19.4%17.1%19.2%13.1%19.7%
Return on invested capital (ROIC)6.7%1.8%8.3%9.1%10.3%9.5%9.4%11.0%7.2%9.7%
Return on assets (ROA)−2.0%0.1%6.0%6.6%6.2%7.2%5.9%6.7%4.4%6.5%
Return on tangible assets−3.6%0.3%11.2%12.8%12.0%12.6%10.2%11.3%7.0%10.1%
Free cash flow margin12.9%12.4%8.8%7.4%15.0%13.0%13.0%13.3%12.6%14.5%
Income quality (OCF / net income)—71.341.441.271.951.501.911.952.561.93
Financial health
Total debt$3.07B$2.72B$3.07B$3.10B$3.21B$2.16B$2.02B$1.70B$1.15B$1.24B
Cash & short-term investments$213.8M$194.6M$276.8M$233.9M$246.3M$229.4M$239.0M$195.4M$163.8M$117.6M
Net debt$2.85B$2.53B$2.79B$2.86B$2.96B$1.93B$1.79B$1.50B$981.3M$1.12B
Debt / equity0.970.790.851.041.261.021.241.291.101.48
Debt / assets0.430.360.370.410.460.390.430.440.390.46
Net debt / EBITDA6.944.352.702.903.612.513.172.962.142.96
Current ratio1.291.411.521.321.231.431.441.611.781.53
Quick ratio1.021.131.161.081.041.211.211.381.541.31
Interest coverage4.71.84.511.08.05.05.85.29.78.6
Working capital$326.7M$409.0M$553.6M$347.4M$240.9M$361.4M$311.1M$339.6M$363.1M$227.2M
Invested capital$6.02B$5.99B$6.39B$5.84B$5.49B$4.05B$3.42B$2.82B$2.03B$1.95B
Tangible asset value$106.9M−$61.9M−$300.1M−$781.7M−$1.18B−$453.1M−$563.5M−$519.7M−$110.7M−$328.2M
Net current asset value−$2.48B−$2.62B−$2.93B−$3.14B−$3.16B−$2.15B−$2.00B−$1.62B−$1.04B−$1.20B
Graham number—$17.35$120.46$111.23$91.83$82.26$61.27$52.84$35.07$35.59
Graham net-net per share−$61.12−$60.93−$67.71−$71.21−$69.98−$50.61−$46.72−$38.84−$27.22−$29.60
Capital allocation
Dividends paid——$25.6M—$45.7M$46.6M$34.5M—$0$0
Share buybacks (net)$360.7M$119.2M$24.2M$38.7M$40.7M$24.0M$18.1M$13.8M$106.9M$12.3M
Dividend payout ratio——5.4%—11.7%12.8%13.7%—0.0%0.0%
Dividends + buybacks / free cash flow69.6%23.8%13.6%13.1%16.2%18.6%15.5%4.6%45.7%5.0%
Capex / revenue5.5%5.8%7.7%8.2%6.5%5.7%5.4%6.2%4.4%3.3%
Capex / operating cash flow29.7%31.7%46.6%52.4%30.1%30.5%29.2%31.7%26.1%18.5%
Capex / depreciation0.540.641.011.070.860.710.710.870.630.44
Stock-based compensation / revenue1.8%1.7%1.7%1.9%2.0%1.9%2.2%2.1%2.4%2.6%
SG&A / revenue18.0%18.5%18.2%16.7%17.5%18.1%18.5%18.5%19.6%21.9%
Efficiency
Days sales outstanding65.067.767.764.465.470.668.772.778.068.8
Days of inventory on hand37.844.244.233.031.834.231.731.133.333.3
Days payables outstanding18.920.826.029.326.523.119.518.423.118.5
Cash conversion cycle (days)83.991.185.968.170.781.780.885.388.283.7
Receivables turnover5.625.405.395.675.585.175.325.024.685.30
Payables turnover19.3017.5814.0212.4413.7615.8218.7119.7915.8119.73
Inventory turnover9.668.258.2611.0511.4610.6811.5311.7410.9710.95
Asset turnover0.550.520.520.540.570.570.610.670.660.70
Average receivables$714.9M$750.6M$766.4M$701.4M$634.1M$565.9M$493.1M$451.1M$397.0M$317.1M
Average payables$144.6M$154.6M$187.4M$202.0M$160.3M$117.0M$88.9M$72.0M$73.2M$52.6M
Average inventory$288.8M$329.4M$318.0M$227.5M$192.4M$173.2M$144.3M$121.4M$105.4M$94.8M
Intangibles / total assets43.5%47.4%48.3%50.0%53.7%47.3%47.5%48.2%40.1%43.6%

Computed from CRL's annual financial statements (latest annual report filed February 18, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.

CRL valuation and financial ratios

Charles River earned a return on equity of −4.4% and a return on invested capital of 6.7% in fiscal 2025. It ended the year with $3.1 billion of debt and $213.8 million in cash and short-term investments, net debt of $2.9 billion. It returned $360.7 million to shareholders: $0 in dividends and $360.7 million in share buybacks, 70% of free cash flow. The share count rose 3.3% from 48.0M to 49.6M over 9 years.

See the CRL income statement, the CRL chart for price history, or the CRL stock overview for the latest quote and news.

CRL key metrics FAQ

What is Charles River's EV/EBITDA?

Charles River's enterprise value was 31.0 times EBITDA at the end of fiscal 2025 (enterprise value $12.7 billion, EBITDA $410.8 million); the current EV/EBITDA is 72.9.

What is Charles River's return on equity?

Charles River's return on equity (ROE) was −4.4% in fiscal 2025: net income of -$144.3 million on average shareholders' equity of $3.3 billion.

What is Charles River's ROIC?

Charles River's return on invested capital was 6.7% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.

How much debt does Charles River have?

Charles River had total debt of $3.1 billion at the end of fiscal 2025, a debt-to-equity ratio of 0.97 and $2.9 billion of net debt (6.94 times EBITDA).

Does Charles River buy back its shares?

Yes. Charles River spent $360.7 million on net share repurchases in fiscal 2025 Shares outstanding changed −4.0% over the year, to 49.6M..

What is Charles River's free cash flow yield?

Charles River generated $518.5 million of free cash flow in fiscal 2025, a free cash flow yield of 5.2% on its market value at year-end ($9.9 billion).

What is Charles River's current ratio?

Charles River's current ratio was 1.29 at the end of fiscal 2025: current assets were 1.29 times current liabilities.

Diagnostics & Research key metrics